S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
First-Time Investor? Here Are 9 Mistakes You Want To Avoid
A gold storm is coming… (Ad)
Ford Stock Going Forward After Big Earnings Flop
Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Closing prices for crude oil, gold and other commodities
AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Indian tycoon Adani hit by more losses, calls for probe
Ford, Starbucks fall; Clorox, Gilead Sciences rise
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
First-Time Investor? Here Are 9 Mistakes You Want To Avoid
A gold storm is coming… (Ad)
Ford Stock Going Forward After Big Earnings Flop
Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Closing prices for crude oil, gold and other commodities
AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Indian tycoon Adani hit by more losses, calls for probe
Ford, Starbucks fall; Clorox, Gilead Sciences rise
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
First-Time Investor? Here Are 9 Mistakes You Want To Avoid
A gold storm is coming… (Ad)
Ford Stock Going Forward After Big Earnings Flop
Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Closing prices for crude oil, gold and other commodities
AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Indian tycoon Adani hit by more losses, calls for probe
Ford, Starbucks fall; Clorox, Gilead Sciences rise
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
First-Time Investor? Here Are 9 Mistakes You Want To Avoid
A gold storm is coming… (Ad)
Ford Stock Going Forward After Big Earnings Flop
Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Closing prices for crude oil, gold and other commodities
AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Indian tycoon Adani hit by more losses, calls for probe
Ford, Starbucks fall; Clorox, Gilead Sciences rise
NASDAQ:FWP

Forward Pharma A/S - FWP Stock Forecast, Price & News

$1.95
0.00 (0.00%)
(As of 12/28/2022)
Add
Compare
Today's Range
$1.95
▼
$1.95
50-Day Range
$1.79
▼
$3.19
52-Week Range
$1.50
▼
$6.48
Volume
N/A
Average Volume
7,484 shs
Market Capitalization
$13.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
FWP stock logo

About Forward Pharma A/S (NASDAQ:FWP) Stock

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Receive FWP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

FWP Stock News Headlines

February 2, 2023 | americanbankingnews.com
Forward Pharma A/S (NASDAQ:FWP) Now Covered by Analysts at StockNews.com
January 25, 2023 | americanbankingnews.com
Forward Pharma A/S (NASDAQ:FWP) Coverage Initiated at StockNews.com
February 4, 2023 | Wall Street Watch Dogs (Ad)
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
December 29, 2022 | msn.com
China Reopening Prospects Lend Some Support to European Equities But Uncertain Outlook Weighs
December 22, 2022 | finanznachrichten.de
Forward Pharma A/S: Forward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital Market
December 19, 2022 | finance.yahoo.com
Forward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital Market
December 9, 2022 | msn.com
European Equities Rise Modestly Friday, But End Week Lower
November 12, 2022 | msn.com
European ADRs Surge Higher as Global Markets React to US Inflation Data
February 4, 2023 | Wall Street Watch Dogs (Ad)
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
October 13, 2022 | msn.com
European ADRs Move Higher in Thursday Trading
September 30, 2022 | forbes.com
How Social Media Analytics Is Transforming Pharma Decision Making
August 10, 2022 | usatoday.com
US forward Matthew Hoppe joins 2nd-tier Middlesbrough
August 8, 2022 | finance.yahoo.com
Fortune and Great Place to Work® Name Forward Networks One of the 2022 Best Small Workplaces™, Ranking #20 Nationally
July 2, 2022 | thestreet.com
Forward Pharma A/S News
April 11, 2022 | investing.com
Forward Pharma Reports FY 21 EPS of $0.02
April 8, 2022 | finance.yahoo.com
Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021
December 16, 2021 | benzinga.com
Forward Pharma Shares Resume Trading, Pull Back From Highs
December 16, 2021 | benzinga.com
Forward Pharma Has Been Granted Australian Patent Titled 'Combination therapy for treatment of multiple sclerosis'
September 7, 2021 | finance.yahoo.com
Why is Forward Pharma Stock Plunging During Premarket Tuesday?
September 6, 2021 | finance.yahoo.com
Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal Hearing
June 28, 2021 | finance.yahoo.com
We're Hopeful That Forward Pharma (NASDAQ:FWP) Will Use Its Cash Wisely
June 14, 2021 | finance.yahoo.com
Is Forward Pharma A/S (FWP) Going to Burn These Hedge Funds?
June 11, 2021 | marketwatch.com
Forward Pharma ADRs Up 26%
April 14, 2021 | finance.yahoo.com
Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020
January 10, 2021 | benzinga.com
Ascendis Pharma A/S Provides Vision 3x3 Update at 39th Annual J.P. Morgan Healthcare Conference
November 19, 2020 | barrons.com
Forward Pharma A/S ADR
November 13, 2020 | seekingalpha.com
Zealand Pharma A/S (ZLDPF) CEO Emmanuel Dulac on Q3 2020 Results - Earnings Call Transcript
See More Headlines
Receive FWP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

FWP Company Calendar

Last Earnings
9/01/2016
Today
2/04/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:FWP
CUSIP
N/A
CIK
1604924
Web
www.forward-pharma.com
Phone
(453) 344-4242
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
18.43
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.09 per share
Price / Book
0.19

Miscellaneous

Outstanding Shares
7,091,000
Free Float
2,023,000
Market Cap
$13.83 million
Optionable
Not Optionable
Beta
1.38

Key Executives

  • Mr. Florian Schonharting M.Sc. (Econ) (Age 53)
    Co-Founder & Chairman
  • Dr. Claus Bo Søndergaard Svendsen M.D. (Age 45)
    Ph.D., Chief Exec. Officer
  • Mr. Thomas Carbone (Age 65)
    VP of Fin. & Controller

Key Competitors

View All Competitors

Insiders & Institutions

View All Institutional Transactions













FWP Stock - Frequently Asked Questions

How have FWP shares performed in 2023?

Forward Pharma A/S's stock was trading at $1.95 on January 1st, 2023. Since then, FWP shares have increased by 0.0% and is now trading at $1.95.
View the best growth stocks for 2023 here.

How were Forward Pharma A/S's earnings last quarter?

Forward Pharma A/S (NASDAQ:FWP) posted its quarterly earnings results on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by $0.06.

What other stocks do shareholders of Forward Pharma A/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Forward Pharma A/S investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), AbbVie (ABBV), Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), Celldex Therapeutics (CLDX), Catalyst Pharmaceuticals (CPRX), Micron Technology (MU), Nabriva Therapeutics (NBRV) and Onconova Therapeutics (ONTX).

What is Forward Pharma A/S's stock symbol?

Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP."

How do I buy shares of Forward Pharma A/S?

Shares of FWP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Forward Pharma A/S's stock price today?

One share of FWP stock can currently be purchased for approximately $1.95.

How much money does Forward Pharma A/S make?

Forward Pharma A/S (NASDAQ:FWP) has a market capitalization of $13.83 million.

How can I contact Forward Pharma A/S?

Forward Pharma A/S's mailing address is OSTERGADE 24A 1, COPENHAGEN G7, 1100. The official website for the company is www.forward-pharma.com. The biotechnology company can be reached via phone at (453) 344-4242 or via email at investors@forward-pharma.com.

This page (NASDAQ:FWP) was last updated on 2/4/2023 by MarketBeat.com Staff